Download
China vows to urge SOEs further to strengthen prevention and control of debt risks
Updated 00:00, 24-Feb-2021
CGTN
01:46

China will continuously urge state-owned enterprises (SOEs) to strengthen the prevention and control of debt risks, according to China's state asset regulator on Tuesday.

"A number of local SOEs defaulted recently, which is caused by the pandemic attack, market fluctuations, and other external reasons as well as internal factors such as blind expansion and poor management," said Peng Huagang, spokesperson of the State-owned Assets Supervision and Administration Commission of the State Council (SASAC) at the press conference.

While the debt risk of central SOEs is generally under control, he noted.

SASAC will formulate the guideline to urge local regulators to accurately identify companies with high risks, properly handle risks in accordance with market-oriented, legalized and internationalized principles, effectively maintaining local financial ecology and stability, Peng said.

Some Chinese enterprises reported corporate bond defaults last year due to a COVID-induced slump in revenue and alterations in the domestic and external economic environment. For example, the AAA-grade bond defaults of China's state-owned Yongmei Group and Brilliance Auto Group have caught public attention and dampened market confidence.

The Huachen Automotive Group Holdings has entered bankruptcy restructuring in November after struggling with debts and loss-making of its self-owned brands and defaulting on a 1-billion-yuan (about $155 million) bond.

The state-owned conglomerate is the parent of Brilliance China Automotive Holdings, which teamed up with German carmaker BMW to form a joint venture BMW Brilliance Automotive in 2003.

More R&D investment

During the past 13th Five-Year Plan period (2016-2020), central SOEs spared no effort to increase R&D investment, which totaled 3.4 trillion yuan, accounting for 25 percent of the country's total investment. In spite of the difficult operation last year, it still maintained a growth rate of 11.3 percent. At present, the number of domestic and foreign research and development institutions in central enterprises has reached 4,360, and there are 91 state key laboratories.

In the country's 14th Five-Year Plan (2021-2025), the government has vowed to expand its presence in forward-looking emerging industries and make market-based operations more flexible and efficient.

"In 2021, we will continue to ensure net profits and total profits of central SOEs grow faster than the national economy. While raising the operating income ratio, increasing the intensity of R&D investment and overall labor productivity, we will keep the asset-liability ratio under steady control," Hao Peng, chairman of SASAC cited.

Officials also said SOEs will move faster to make breakthroughs in a number of cutting-edge technologies in artificial intelligence, space technology, and equipment manufacturing, and forge a number of long-board technologies in electric power equipment, communications equipment, high-speed rail, nuclear power, and new energy, so as to increase the supply of generic technologies in the industry.

SOEs that comprise these key industries are positioned to receive increasing support, as they attempt to transform their business models and increase competitiveness, both at home and abroad.

Hard-earned growth

Data showed that at the end of last year, SOEs' total assets under supervision reached 218.3 trillion yuan, whose operating income in 2020 was 59.5 trillion yuan, and total profits reached 3.5 trillion yuan.

Among them, central SOEs achieved net profits of 1.4 trillion yuan, a year-on-year increase of 2.1 percent. It's not a high growth rate, but officials said growth isn't easy in unfavorable conditions.

"We still remember how in Wuhan, Hebei Province, central SOEs built two hospitals in less than two weeks, produced urgently needed protective materials, and spared no effort to ensure the supply of electricity, food, and fuel to stabilize market prices. Some also took the lead in vaccine research, providing much-needed support in the fight against the pandemic," Hao said.

(CGTN's Liu Jiaxin also contributed to this story.)

Search Trends